{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:41:07Z","timestamp":1789566067229,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["224024\/Z\/21\/Z"],"award-info":[{"award-number":["224024\/Z\/21\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["204672\/Z\/16\/Z"],"award-info":[{"award-number":["204672\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203134\/A\/16\/Z."],"award-info":[{"award-number":["203134\/A\/16\/Z."]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203134\/A\/16"],"award-info":[{"award-number":["203134\/A\/16"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jbc.2024.108049","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T09:50:53Z","timestamp":1733737853000},"page":"108049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pharmacological and structural understanding of the Trypanosoma cruzi proteasome provides key insights for developing site-specific inhibitors"],"prefix":"10.1016","volume":"301","author":[{"given":"Thomas C.","family":"Eadsforth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah S.","family":"Torrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma V.","family":"Edgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna M.","family":"MacLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon M.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4135-5604","authenticated-orcid":false,"given":"John","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9512-3828","authenticated-orcid":false,"given":"David W.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent L.G.","family":"Postis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3171-3519","authenticated-orcid":false,"given":"Manu","family":"De Rycker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2024.108049_bib1","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.3390\/ijms20112783","article-title":"A\u00a0structure-based drug discovery paradigm","volume":"20","author":"Batool","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2024.108049_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature14451","article-title":"A\u00a0novel multiple-stage antimalarial agent that inhibits protein synthesis","volume":"522","author":"Baragana","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.108049_bib3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41586-018-0356-z","article-title":"Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis","volume":"560","author":"Wyllie","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.108049_bib4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.15252\/emmm.201607370","article-title":"Targeting Toxoplasma gondii CPSF3 as a new approach to control toxoplasmosis","volume":"9","author":"Palencia","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jbc.2024.108049_bib5","doi-asserted-by":"crossref","first-page":"9616","DOI":"10.1073\/pnas.1807915115","article-title":"Clinical and veterinary trypanocidal benzoxaboroles target CPSF3","volume":"115","author":"Wall","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.108049_bib6","doi-asserted-by":"crossref","first-page":"16159","DOI":"10.1021\/acs.jmedchem.1c01437","article-title":"DNDI-6148: a novel benzoxaborole preclinical candidate for the treatment of visceral leishmaniasis","volume":"64","author":"Mowbray","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2024.108049_bib7","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/s41564-022-01211-y","article-title":"Discovery of an orally active benzoxaborole prodrug effective in the treatment of Chagas disease in non-human primates","volume":"7","author":"Padilla","year":"2022","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.jbc.2024.108049_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007315","article-title":"The trypanocidal benzoxaborole AN7973 inhibits trypanosome mRNA processing","volume":"14","author":"Begolo","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jbc.2024.108049_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14574","article-title":"A\u00a0potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue","volume":"8","author":"Sonoiki","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.108049_bib10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature19339","article-title":"Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness","volume":"537","author":"Khare","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.108049_bib11","doi-asserted-by":"crossref","first-page":"10773","DOI":"10.1021\/acs.jmedchem.0c00499","article-title":"Discovery and characterization of clinical candidate LXE408 as a kinetoplastid-selective proteasome inhibitor for the treatment of leishmaniases","volume":"63","author":"Nagle","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2024.108049_bib12","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.1021\/acs.jmedchem.1c00047","article-title":"Scaffold-hopping strategy on a series of proteasome inhibitors led to a preclinical candidate for the treatment of visceral leishmaniasis","volume":"64","author":"Thomas","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2024.108049_bib13","doi-asserted-by":"crossref","first-page":"9318","DOI":"10.1073\/pnas.1820175116","article-title":"Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition","volume":"116","author":"Wyllie","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.108049_bib14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.beha.2017.09.001","article-title":"Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting","volume":"30","author":"Ciechanover","year":"2017","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.jbc.2024.108049_bib15","article-title":"Ubiquitination and the proteasome as drug targets in trypanosomatid diseases","volume":"8","author":"Bijlmakers","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.jbc.2024.108049_bib16","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/14728222.2019.1685981","article-title":"The proteasome as a target for protozoan parasites","volume":"23","author":"Xie","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jbc.2024.108049_bib17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.trsl.2018.04.007","article-title":"The proteasome as a target to combat malaria: hits and misses","volume":"198","author":"Krishnan","year":"2018","journal-title":"Transl. Res."},{"key":"10.1016\/j.jbc.2024.108049_bib18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1124\/pr.117.015370","article-title":"A\u00a0practical review of proteasome pharmacology","volume":"71","author":"Thibaudeau","year":"2019","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jbc.2024.108049_bib19","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1021\/acscentsci.7b00252","article-title":"The proteasome in modern drug discovery: second Life of a highly valuable drug target","volume":"3","author":"Cromm","year":"2017","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.jbc.2024.108049_bib20","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1021\/acs.jmedchem.8b00026","article-title":"Selective substrates and activity-based probes for imaging of the human constitutive 20S proteasome in cells and blood samples","volume":"61","author":"Rut","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2024.108049_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10900","article-title":"A\u00a0unified mechanism for proteolysis and autocatalytic activation in the 20S proteasome","volume":"7","author":"Huber","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.108049_bib22","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S1074-5521(01)00080-1","article-title":"Substrate specificity of the human proteasome","volume":"8","author":"Harris","year":"2001","journal-title":"Chem. Biol."},{"key":"10.1016\/j.jbc.2024.108049_bib23","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1002\/cbic.202000375","article-title":"Structure-based design of fluorogenic substrates selective for human proteasome subunits","volume":"21","author":"Maurits","year":"2020","journal-title":"Chembiochem"},{"key":"10.1016\/j.jbc.2024.108049_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00309-19","article-title":"Identification of novel trypanosoma cruzi proteasome inhibitors using a luminescence-based high-throughput screening assay","volume":"63","author":"Zmuda","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jbc.2024.108049_bib25","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1021\/cb5001263","article-title":"Assessing subunit dependency of the Plasmodium proteasome using small molecule inhibitors and active site probes","volume":"9","author":"Li","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2024.108049_bib26","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1074-5521(01)00056-4","article-title":"Proteasome inhibitors: from research tools to drug candidates","volume":"8","author":"Kisselev","year":"2001","journal-title":"Chem. Biol."},{"key":"10.1016\/j.jbc.2024.108049_bib27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41579-022-00777-y","article-title":"Anti-trypanosomatid drug discovery: progress and challenges","volume":"21","author":"De Rycker","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jbc.2024.108049_bib28","first-page":"33","article-title":"Chagas disease in Latin America: an epidemiological update based on 2010 estimates","volume":"90","year":"2015","journal-title":"Wkly Epidemiol. Rec."},{"key":"10.1016\/j.jbc.2024.108049_bib29","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","article-title":"Chagas disease","volume":"391","author":"P\u00e9rez-Molina","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jbc.2024.108049_bib30","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S1473-3099(13)70002-1","article-title":"Global economic burden of Chagas disease: a computational simulation model","volume":"13","author":"Lee","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jbc.2024.108049_bib31","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/17512433.2018.1509704","article-title":"Clinical and pharmacological profile of benznidazole for treatment of Chagas disease","volume":"11","author":"M\u00fcller Kratz","year":"2018","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.jbc.2024.108049_bib32","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","article-title":"Randomized trial of posaconazole and benznidazole for chronic Chagas' disease","volume":"370","author":"Molina","year":"2014","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.jbc.2024.108049_bib33","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1473-3099(17)30538-8","article-title":"Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial","volume":"18","author":"Torrico","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jbc.2024.108049_bib34","doi-asserted-by":"crossref","first-page":"E2564","DOI":"10.1073\/pnas.1604935113","article-title":"biGBac enables rapid gene assembly for the expression of large multisubunit protein complexes","volume":"113","author":"Weissmann","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.108049_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/bs.mie.2020.12.019","article-title":"Effective production of oligomeric membrane proteins by EarlyBac-insect cell system","volume":"653","author":"Furukawa","year":"2021","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jbc.2024.108049_bib36","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/nmeth983","article-title":"Protein complex expression by using multigene baculoviral vectors","volume":"3","author":"Fitzgerald","year":"2006","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jbc.2024.108049_bib37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.molcel.2019.07.014","article-title":"Characterization of fully recombinant human 20S and 20S-PA200 proteasome complexes","volume":"76","author":"Toste Rego","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2024.108049_bib38","doi-asserted-by":"crossref","first-page":"8621","DOI":"10.1038\/s41467-024-53022-w","article-title":"Structural elucidation of recombinant Trichomonas vaginalis 20S proteasome bound to covalent inhibitors","volume":"15","author":"Silhan","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.108049_bib39","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1038\/s41564-019-0524-4","article-title":"The structure of the PA28-20S proteasome complex from Plasmodium falciparum and implications for proteostasis","volume":"4","author":"Xie","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.jbc.2024.108049_bib40","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.str.2014.11.017","article-title":"Crystal structure of the human 20S proteasome in complex with carfilzomib","volume":"23","author":"Harshbarger","year":"2015","journal-title":"Structure"},{"key":"10.1016\/j.jbc.2024.108049_bib41","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cell.2011.12.030","article-title":"Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificity","volume":"148","author":"Huber","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2024.108049_bib42","doi-asserted-by":"crossref","first-page":"10413","DOI":"10.1021\/acs.jmedchem.3c00582","article-title":"Structure-guided design and synthesis of a pyridazinone series of trypanosoma cruzi proteasome inhibitors","volume":"66","author":"Thomas","year":"2023","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2024.108049_bib43","first-page":"23","article-title":"Phenotypic drug discovery for human African trypanosomiasis: a powerful approach","volume":"5","author":"Buckner","year":"2020","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.jbc.2024.108049_bib44","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.chembiol.2016.12.016","article-title":"Inhibition of the proteasome beta2 site sensitizes triple-negative breast cancer cells to beta5 inhibitors and suppresses Nrf1 activation","volume":"24","author":"Weyburne","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jbc.2024.108049_bib45","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1126\/science.7725107","article-title":"Proteasome from Thermoplasma acidophilum: a threonine protease","volume":"268","author":"Seemuller","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jbc.2024.108049_bib46","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1021\/jm801329v","article-title":"Design and synthesis of an orally bioavailable and selective peptide epoxyketone proteasome inhibitor (PR-047)","volume":"52","author":"Zhou","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2024.108049_bib47","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41594-024-01262-1","article-title":"Mechanism of autocatalytic activation during proteasome assembly","volume":"31","author":"Velez","year":"2024","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jbc.2024.108049_bib48","doi-asserted-by":"crossref","first-page":"E6863","DOI":"10.1073\/pnas.1806109115","article-title":"Antimalarial proteasome inhibitor reveals collateral sensitivity from intersubunit interactions and fitness cost of resistance","volume":"115","author":"Kirkman","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.108049_bib49","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2207200119","article-title":"Structural insights into the human PA28-20S proteasome enabled by efficient tagging and purification of endogenous proteins","volume":"119","author":"Zhao","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.108049_bib50","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nature16936","article-title":"Structure- and function-based design of Plasmodium-selective proteasome inhibitors","volume":"530","author":"Li","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.108049_bib52","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1073\/pnas.1018301108","article-title":"Depletion of antibiotic targets has widely varying effects on growth","volume":"108","author":"Wei","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.108049_bib53","doi-asserted-by":"crossref","first-page":"e34039","DOI":"10.7554\/eLife.34039","article-title":"Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure","volume":"7","author":"Sanchez-Valdez","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.jbc.2024.108049_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006612","article-title":"Development of Trypanosoma cruzi in\u00a0vitro assays to identify compounds suitable for progression in Chagas' disease drug discovery","volume":"12","author":"MacLean","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jbc.2024.108049_bib55","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S1074-5521(96)90164-7","article-title":"Just add water! The effect of water on the specificity of protein-ligand binding sites and its potential application to drug design","volume":"3","author":"Ladbury","year":"1996","journal-title":"Chem. Biol."},{"key":"10.1016\/j.jbc.2024.108049_bib56","doi-asserted-by":"crossref","first-page":"8302","DOI":"10.1038\/s41467-023-44077-2","article-title":"Structures revealing mechanisms of resistance and collateral sensitivity of Plasmodium falciparum to proteasome inhibitors","volume":"14","author":"Hsu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.108049_bib57","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.chembiol.2024.07.001","article-title":"Identification of potent and reversible piperidine carboxamides that are species-selective orally active proteasome inhibitors to treat malaria","volume":"31","author":"Lawong","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jbc.2024.108049_bib58","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2107213118","article-title":"Design of proteasome inhibitors with oral efficacy in\u00a0vivo against Plasmodium falciparum and selectivity over the human proteasome","volume":"118","author":"Xie","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.108049_bib59","first-page":"61","article-title":"Nono caso-aut\u00f3ctone de doen\u00e7a de Chagas registrado no estado do Par\u00e1, Brasil (Nota pr\u00e9via)","author":"Silveira FT","year":"1979","journal-title":"Hil\u00e9ia M\u00e9dica"},{"key":"10.1016\/j.jbc.2024.108049_bib60","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1107\/S2052252520000081","article-title":"Estimation of high-order aberrations and anisotropic magnification from cryo-EM data sets in RELION-3.1","volume":"7","author":"Zivanov","year":"2020","journal-title":"IUCrJ"},{"key":"10.1016\/j.jbc.2024.108049_bib61","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2024.108049_bib62","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1107\/S0907444909042589","article-title":"Molecular replacement with MOLREP","volume":"66","author":"Vagin","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2024.108049_bib63","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2024.108049_bib64","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1107\/S2059798318000979","article-title":"Overview of refinement procedures within REFMAC5: utilizing data from different sources","volume":"74","author":"Kovalevskiy","year":"2018","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.jbc.2024.108049_bib65","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.jbc.2024.108049_bib66","doi-asserted-by":"crossref","first-page":"W521","DOI":"10.1093\/nar\/gkae241","article-title":"The EMBL-EBI Job Dispatcher sequence analysis tools framework in 2024","volume":"52","author":"Madeira","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2024.108049_bib67","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/bioinformatics\/btp033","article-title":"Jalview Version 2--a multiple sequence alignment editor and analysis workbench","volume":"25","author":"Waterhouse","year":"2009","journal-title":"Bioinformatics"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824025511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824025511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:18:55Z","timestamp":1778635135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925824025511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0021925824025511"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2024.108049","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological and structural understanding of the Trypanosoma cruzi proteasome provides key insights for developing site-specific inhibitors","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2024.108049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"108049"}}